EAST-LC: Randomized Controlled Phase III Trial of S-1 Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Who Had Received a Platinum-Based Treatment
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdw383.18
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Elsevier BV